Is grade 2 diastolic dysfunction or an E/e' ratio greater than 14 a better criterion for diagnosing heart failure with preserved ejection fraction (HFpEF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

E/e' >14 is Better Than Grade 2 Diastolic Dysfunction for Identifying HFpEF

E/e' >14 is the superior criterion because it is one of the three validated parameters specifically recommended for identifying elevated left atrial pressure (LAP) in HFpEF patients, whereas grade 2 diastolic dysfunction is a composite diagnosis that itself requires E/e' >14 as one of its defining criteria. 1

Why E/e' >14 is the Preferred Metric

Direct Measurement vs. Composite Grade

The fundamental issue is that grade 2 diastolic dysfunction is not a standalone measurement—it's a diagnostic conclusion that requires meeting specific cutoff values, including E/e' >14 itself 1. According to the 2016 ASE/EACVI guidelines, to diagnose grade 2 diastolic dysfunction in patients with preserved ejection fraction, you need:

  • An E/A ratio between 0.8-2.0 (the indeterminate zone)
  • Plus at least 2 of 3 parameters meeting cutoffs:
    • Average E/e' >14
    • LA volume index >34 mL/m²
    • TR velocity >2.8 m/sec

Therefore, using "grade 2 diastolic dysfunction" as your criterion is circular reasoning—you're already using E/e' >14 to define it.

Validation for HFpEF Specifically

The guidelines explicitly state that "all three indices have been shown to be of value in identifying patients with HFpEF" 1, with E/e' >14 being one of the three validated cutoff values for elevated LAP in this population.

Research confirms E/e' correlates with invasively measured pulmonary capillary wedge pressure both at rest (r=0.63) and during exercise (r=0.57) 2. While the correlation is modest, E/e' demonstrated a hazard ratio of 1.05 per unit increase for the combined outcome of all-cause mortality and cardiovascular hospitalization 3.

Clinical Application Algorithm

When evaluating for HFpEF:

  1. Start with E/e' measurement (use average of septal and lateral measurements)

    • E/e' >14 → Elevated LAP likely, consistent with HFpEF
    • E/e' <8 → Normal LAP likely, HFpEF less likely
    • E/e' 8-14 → Indeterminate zone
  2. In the indeterminate zone (E/e' 8-14), add:

    • LA volume index (>34 mL/m² suggests elevated LAP)
    • TR velocity (>2.8 m/sec suggests elevated LAP)
    • If ≥2 of 3 parameters abnormal → Grade 2 diastolic dysfunction with elevated LAP
  3. Consider exercise testing if resting parameters are inconclusive

    • Exercise E/e' >14 improves sensitivity to 90% (vs. 34-60% at rest alone) 2
    • This helps rule out HFpEF when negative

Critical Caveats

Specificity vs. Sensitivity Trade-off

E/e' >14 has high specificity (91-98%) but poor sensitivity (24-37%) 1. This means:

  • If E/e' >14 → You can be confident LAP is elevated
  • If E/e' ≤14 → You cannot exclude HFpEF (many patients will be missed)

Adding exercise E/e' >14 dramatically improves sensitivity to 90% but reduces specificity to 71% 2. This makes exercise testing valuable for ruling out HFpEF rather than ruling it in.

The Limitations of Both Approaches

A systematic review found that E/e' has only modest correlation with invasive filling pressures in HFpEF 3, 4. The diagnostic accuracy is limited, with substantial risks of bias in validation studies 4. However, E/e' remains the best-established single parameter available 3.

Grade 2 diastolic dysfunction suffers from the same limitations since it incorporates E/e', plus it adds complexity by requiring multiple measurements that may be discordant.

Bottom Line for Clinical Practice

Use E/e' >14 as your primary criterion because:

  • It's a direct, quantifiable measurement
  • It has the strongest evidence base among individual parameters
  • It's specifically validated for HFpEF populations
  • Grade 2 diastolic dysfunction already requires E/e' >14 as part of its definition

When E/e' is 8-14 (indeterminate), integrate LA volume index and TR velocity to improve diagnostic accuracy. If clinical suspicion remains high despite normal resting parameters, proceed to exercise echocardiography with E/e' measurement during stress to improve sensitivity 2.

The reality is that no single resting echocardiographic parameter reliably diagnoses HFpEF 3, 2, but E/e' >14 provides the most direct and evidence-based starting point for assessment.

Related Questions

For a patient with diastolic dysfunction and heart failure with preserved ejection fraction, chronic venous insufficiency, low ferritin (17.7 ng/mL) and low‑normal hemoglobin, preserved ejection fraction, a slowly rising E/e′ ratio of 9.2, normal left atrial volume index (22.1 mL/m²), and mild bilateral ankle pitting edema, is eplerenone 25 mg daily indicated and could it cause the ankle edema?
What echocardiographic parameters are used to diagnose heart failure with preserved ejection fraction (HFpEF)?
What is the expected survival duration for a patient with diastolic heart failure (heart failure with preserved ejection fraction)?
In a patient being evaluated for heart failure with preserved ejection fraction, does a normal mitral inflow E to tissue Doppler E' ratio exclude elevated left‑ventricular filling pressures and rule out HFpEF?
What is the role of diastolic dysfunction in causing symptoms of heart failure with preserved ejection fraction?
How do I interpret elevated serum free kappa and lambda light chain levels in a patient with chronic kidney disease?
What is gallstone ileus?
Which hormone blood tests should be ordered to evaluate endocrine function?
Is a percutaneous Watchman left atrial appendage closure device safe to implant in a 53‑year‑old man one year after mitral bioprosthetic valve replacement, tricuspid annuloplasty, and left anterior descending artery bypass, given his chronic liver disease (Child‑Pugh class A or B) and current anticoagulation status?
What is the appropriate intravenous therapy for an acute gout flare in a patient with stage IV chronic kidney disease?
Given that I live three hours from a pelvic‑floor therapy center, making more than one in‑person session per week difficult, should I consider relocating now to facilitate intensive pelvic‑floor therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.